2011 annual financial data
GT Biopharma 2011 Net margin
Direct answer
Net margin was -14,230.77%.
Operating income was -3,928,000 USD and net income was -3,700,000 USD.
Operating cash flow was -963,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 26,000 USD
- Operating income
- -3,928,000 USD
- Net income
- -3,700,000 USD
- Operating cash flow
- -963,000 USD